Skip to main content
Premium Trial:

Request an Annual Quote

Target Discovery and PrecisionMed to Study Peptides in Childhood Autism

NEW YORK, April 6 (GenomeWeb News) - Target Discovery and PrecisionMed will collaborate to study the role of certain peptides in childhood autism, the companies said today.

 

Under the agreement, Target Discovery, based in Palo Alto, Calif., will use its technology to determine the source of opioid-like peptides in samples from autistic children provided by PrecisionMed, located in San Diego.

 

Target Discovery has been working on a protein separation platform based on capillary electrophoresis and mass spectrometry.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.